AtHome Pediatric Care Devices Could Address Access Gap for Millions of Children Signos Secures 20M in Funding to Expand AIPowered Glucose Monitoring for Weight Loss Polymarket Traders Bet SpaceX OpenAI Could Surpass Berkshire Hathaway on First Trading Day TikToks Monetization Model How Creators and Businesses Generate Sustainable Income Indian Rupee Rebounds Past 96 on Strong RBI Intervention SpaceX IPO Speculation Nvidia Earnings Focus and Bezos AI Bubble Comments Lead Market Watch Standex International SXI Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher LUNR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Positive Stock Reaction VSAT Q1 2026 Earnings Stellar EPS Beat Drives Positive Market Reaction EXK Q1 2026 Earnings EPS Smashes Estimates by Nearly 60 Stock Edges Lower MSFT Q1 2026 Earnings EPS Beat Highlights Resilient Cloud and AI Momentum ITT Inc Q1 2026 Earnings Strong Profit Beat Despite Mixed Demand Signals BioVie Inc BIVI Faces Selling Pressure as Shares Slide 59 Xsolla SPAC 1 XSLL Holds Steady at 990 as Market Awaits Catalysts Foremost Clean Energy FMST Advances 124 as Clean Energy Sector Finds Footing Blue Owl Capital OBDC Slightly Down Holds Between Defined Support and Resistance Levels Exelon EXC Slides Slightly as Utility Sector Faces Mixed Sentiment Indian Equity Markets Wobble Hind Zinc SBI Force Motors Drive Activity Amid Mixed Sector Performance ALMS Q1 2026 Earnings NarrowerthanExpected Loss and Pipeline Progress Fifth Era Acquisition Corp I FERA Holds Steady at 1038 as SPAC Market Awaits Catalyst QS Q1 2026 Earnings Narrower Loss Surprises But Stock Falls 215 Amid Continued PreRevenue Phase General Mills Q1 2026 Earnings EPS Misses Estimates by Nearly 13 as Stock Edges Higher PAY Q1 2026 Earnings EPS Surpasses Estimates by Nearly 21 DUOT Q1 2026 Earnings WiderThanExpected Loss But Shares Surge GNS Q4 2022 Earnings Massive EPS Miss as Reported Loss Exceeds Estimates by Wide Margin Forrester Research Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss